O assunto mereceu bastante destaque na imprensa internacional, recentemente, em razão da divulgação de dois relatórios. Um relatório, divulgado em Paris, foi elaborado pelo Comitê de Assuntos Sociais, de Saúde de da Família da Assembléia Parlamentar do Conselho da Europa. O segundo foi resultado de uma investigação do British Medical Journal e do Bureau of Investigative Journalism, de Londres. Ambos criticam que os três experts da OMS receberam recursos por consultoria da Roche e da GlaxoSmithKline, sem que isto tenha sido alertado.
A possibilidade de um conflito de interesse foi negligenciada pela OMS?
Veja a notícia em grandes jornais dos EEUU, Espanha, Inglaterra e França.
No Washington Post:
Reports accuse WHO of exaggerating H1N1 threat, possible ties to drug makers
By Rob Stein
Washington Post Staff Writer
Friday, June 4, 2010; 3:52 PM
European criticism of the World Health Organization's handling of the H1N1 pandemic intensified Friday with the release of two reports that accused the agency of exaggerating the threat posed by the virus and failing to disclose possible influence by the pharmaceutical industry on its recommendations for how countries should respond.
The WHO's response caused widespread, unnecessary fear and prompted countries around the world to waste millions of dollars, according to one report. leia na íntegra.
No El Pais
La OMS ocultó que sus expertos en gripe A cobraron de farmacéuticas
El organismo no informó a los Gobiernos cuando les instó a reservar antivirales
JAVIER SAMPEDRO - Madrid - 05/06/2010
La gestión de la pandemia de gripe A por la Organización Mundial de la Salud (OMS) fue poco transparente. Según un estudio del British Medical Journal (BMJ), una de las revistas médicas de referencia, un informe clave de la OMS ocultó los vínculos financieros entre sus expertos y las farmacéuticas Roche y Glaxo, fabricantes de Tamiflu y Relenza, los fármacos antivirales contra el virus H1N1. Ese fue el informe que instó a los Gobiernos a apilar reservas de esos medicamentos, por valor de unos 6.000 millones de dólares (4.900 millones de euros). Las críticas del British Medical Journal se suman a las del Consejo de Europa, que recientemente también acusó a la OMS de opacidad, aunque por otra razón: que los 16 miembros del comité de emergencia que asesoró durante la crisis a la directora del organismo, Margaret Chang, son secretos. leia na íntegra.
No The Guardian
Report condemns swine flu experts' ties to big pharma
Trio of scientists who urged stockpiling had previously been paid, says report
Randeep Ramesh, social affairs editor
The Guardian, Friday 4 June 201
Scientists who drew up the key World Health Organisation guidelines advising governments to stockpile drugs in the event of a flu pandemic had previously been paid by drug companies which stood to profit, according to a report out today.
An investigation by the British Medical Journal and the Bureau of Investigative Journalism, the not-for-profit reporting unit, shows that WHO guidance issued in 2004 was authored by three scientists who had previously received payment for other work from Roche, which makes Tamiflu, and GlaxoSmithKline (GSK), manufacturer of Relenza.
City analysts say that pharmaceutical companies banked more than $7bn (£4.8bn) as governments stockpiled drugs. The issue of transparency has risen to the forefront of public health debate after dramatic predictions last year about a swine flu pandemic did not come true. Leia na íntegra.
Le Monde
Grippe A : nouvelles accusations contre l'OMS
Article publié le 06 Juin 2010
Par Paul Benkimoun
Extrait :
Le « British Medical Journal » souligne les liens entre les experts de l'Organisation mondiale de la santé et les laboratoires. Les critiques sur la manière dont l'Organisation mondiale de la santé (OMS) a répondu à la pandémie grippale sont montées d'un cran, vendredi 4 juin, avec la publication coordonnée d'une enquête menée conjointement par le British Medical Journal (BMJ) et le Bureau of Investigative Journalism de Londres, et du rapport adopté le même jour par la commission de la santé de l'Assemblée parlementaire du Conseil de l'Europe. O texto é pago.
A ilustração se refere à peste negra. Não se refere à epidemia de gripe H1N1, mais ligada à epidemia de falta de ética.
Na ponta daquele bico (do personagem da ilustração) ia um chumaço com ervas aromáticas e antissépticas.
ResponderExcluirFedia ontem e fede hoje!